BMS Wins FDA Approval for Drug to Treat Rare Form of Cardiac Disease The U.S. Food & Drug Administration has granted approval to Bristol Meyers Squibb’s drug Camzyos to improve cardiac function in adults with a ...
BMS Awards $8 Million in Health Equity Grants to Improve Access to Care Bristol Myers Squibb this week announced $7.965 million in new health equity grants to 24 U.S. nonprofit organizations working to improve access and ...
NJBIA, Healthcare Groups Oppose Bill Mandating Employment Conditions after Sale of Healthcare Facilities